Rare diseases
Investigational molecules
Locations
Back to Germany993 clinical trials in Essen, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)KAI-9531 in Adults With Obesity or Overweight and Diabetes
GermanyA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
GermanyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyEfficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
GermanyStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
GermanyStudy on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen
GermanyPegcetacoplan to Prevent Recurrence of C3 Glomerulopathy or Primary Immune‑Complex MPGN in Adolescent and Adult Kidney Transplant Recipients
GermanyEvaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant
GermanyPetosemtamab versus cetuximab plus drug combination as first‑line treatment for adults with metastatic left‑sided colorectal cancer
GermanyGermanyStudy of VSA012 Sodium in Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Complement Inhibitor‑Naïve or Have Persistent Anemia on C5 Inhibitor Therapy
GermanyEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic colorectal cancer, breast cancer, and lymphoma treatments. Studies evaluate novel therapeutic combinations and targeted approaches for various cancer types.
Research includes evaluation of new drug combinations and immunotherapy approaches.
Studies examining preventive treatments for respiratory syncytial virus and related infections. Research focuses on vaccine development and immune response in different age groups.
Emphasis on protecting vulnerable populations including older adults and at-risk individuals.
Clinical research addressing Alzheimer's disease and acute cerebral ischemic stroke. Investigations into novel therapeutic approaches and diagnostic tools.
Focus on improving patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
